Rel-1-(3,5-bis(trifluoromethyl)phenyl)-3-((1S,2S)-2-(isoindolin-2-yl)cyclohexyl)thiourea

Catalog No. :
ACCGZD502
CAS No. :
2209086-51-9
Molecular Formula :
C23H23F6N3S
Molecular Weight :
487.51

IUPAC Name:1-(3,5-bis(trifluoromethyl)phenyl)-3-((1S,2S)-2-(isoindolin-2-yl)cyclohexyl)thiourea

Rel-1-(3,5-bis(trifluoromethyl)phenyl)-3-((1S,2S)-2-(isoindolin-2-yl)cyclohexyl)thiourea structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg98%$125.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameRel-1-(3,5-bis(trifluoromethyl)phenyl)-3-((1S,2S)-2-(isoindolin-2-yl)cyclohexyl)thiourea
IUPAC Name1-(3,5-bis(trifluoromethyl)phenyl)-3-((1S,2S)-2-(isoindolin-2-yl)cyclohexyl)thiourea
Molecular FormulaC23H23F6N3S
Molecular Weight487.51
SMILESS=C(N[C@@H]1[C@@H](N2CC3=C(C=CC=C3)C2)CCCC1)NC4=CC(C(F)(F)F)=CC(C(F)(F)F)=C4
InChI KeyKIDBBKIWFZMJNT-PMACEKPBSA-N
SynonymThiourea, N-[3,5-bis(trifluoromethyl)phenyl]-N'-[(1R,2R)-2-(1,3-dihydro-2H-isoindol-2-yl)cyclohexyl]-, rel-;Rel-1-(3,5-bis(trifluoromethyl)phenyl)-3-((1S,2S)-2-(isoindolin-2-yl)cyclohexyl)thiourea;rel-N-[3,5-Bis(trifluoromethyl)phenyl]-N'-[(1S,2S)-2-(1,3-dihydro-2H-isoindol-2-yl)cyclohexyl]thiourea
CAS No.2209086-51-9

Synthetic Route by SureRoute

1. ACCGZD502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCGZD502 route product structure diagram
    ACCGZD5022209086-51-9
Inquiry

2. ACCGZD502 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACNRTS705 route compound structure diagram
    ACNRTS705328-74-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACCGZD502 route product structure diagram
    ACCGZD5022209086-51-9
Inquiry

Comments (0)